Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) EBT (2016 - 2023)

Historic EBT for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$22.0 million.

  • Mesoblast's EBT fell 210.16% to -$22.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$82.1 million, marking a year-over-year increase of 1035.64%. This contributed to the annual value of -$101.8 million for FY2025, which is 1550.25% down from last year.
  • Mesoblast's EBT amounted to -$22.0 million in Q2 2023, which was down 210.16% from -$18.6 million recorded in Q1 2023.
  • Mesoblast's 5-year EBT high stood at -$7.4 million for Q3 2019, and its period low was -$35.9 million during Q2 2020.
  • Over the past 5 years, Mesoblast's median EBT value was -$23.3 million (recorded in 2019), while the average stood at -$22.9 million.
  • Per our database at Business Quant, Mesoblast's EBT soared by 6330.35% in 2019 and then crashed by 24080.37% in 2020.
  • Quarter analysis of 5 years shows Mesoblast's EBT stood at -$26.9 million in 2019, then rose by 4.6% to -$25.6 million in 2020, then decreased by 1.59% to -$26.0 million in 2021, then increased by 5.64% to -$24.6 million in 2022, then increased by 10.58% to -$22.0 million in 2023.
  • Its EBT was -$22.0 million in Q2 2023, compared to -$18.6 million in Q1 2023 and -$24.6 million in Q4 2022.